138 related articles for article (PubMed ID: 37355264)
1. Attendance characteristics of the breast and colorectal cancer screening programmes in a highly urbanised region of the Netherlands: a retrospective observational study.
Bongaerts THG; Büchner FL; de Munck L; Elferink MAG; Guicherit OR; Numans ME
BMJ Open; 2023 Jun; 13(6):e071354. PubMed ID: 37355264
[TBL] [Abstract][Full Text] [Related]
2. Perceptions and beliefs of general practitioners on their role in the cancer screening programmes in the Netherlands: a mixed-methods study.
Bongaerts THG; Büchner FL; Nierkens V; Crone MR; Guicherit OR; Numans ME
BMC Prim Care; 2024 Apr; 25(1):129. PubMed ID: 38658815
[TBL] [Abstract][Full Text] [Related]
3. Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands.
Kregting LM; Olthof EMG; Breekveldt ECH; Aitken CA; Heijnsdijk EAM; Toes-Zoutendijk E; de Koning HJ; van Ravesteyn NT
Eur J Cancer; 2022 Nov; 175():180-186. PubMed ID: 36126478
[TBL] [Abstract][Full Text] [Related]
4. Perspectives on cancer screening participation in a highly urbanized region: a Q-methodology study in The Hague, the Netherlands.
Bongaerts THG; Büchner FL; Crone MR; van Exel J; Guicherit OR; Numans ME; Nierkens V
BMC Public Health; 2022 Oct; 22(1):1925. PubMed ID: 36243684
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands--associations with stage at diagnosis and survival.
Aarts MJ; Voogd AC; Duijm LE; Coebergh JW; Louwman WJ
Breast Cancer Res Treat; 2011 Jul; 128(2):517-25. PubMed ID: 21290176
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.
Breekveldt ECH; Lansdorp-Vogelaar I; Toes-Zoutendijk E; Spaander MCW; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Nagtegaal ID; Krul MF; Kok NFM; Kuhlmann KFD; Vink GR; van Leerdam ME; Elferink MAG;
Lancet Gastroenterol Hepatol; 2022 Jan; 7(1):60-68. PubMed ID: 34822762
[TBL] [Abstract][Full Text] [Related]
8. Determinants of (non-)attendance at the Dutch cancer screening programmes: A systematic review.
Bongaerts TH; Büchner FL; Middelkoop BJ; Guicherit OR; Numans ME
J Med Screen; 2020 Sep; 27(3):121-129. PubMed ID: 31801039
[TBL] [Abstract][Full Text] [Related]
9. Attending the breast screening programme after breast cancer treatment: a population-based study.
de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S
Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800
[TBL] [Abstract][Full Text] [Related]
10. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England.
von Wagner C; Baio G; Raine R; Snowball J; Morris S; Atkin W; Obichere A; Handley G; Logan RF; Rainbow S; Smith S; Halloran S; Wardle J
Int J Epidemiol; 2011 Jun; 40(3):712-8. PubMed ID: 21330344
[TBL] [Abstract][Full Text] [Related]
11. Trends in socioeconomic inequalities in cervical, breast, and colorectal cancer screening participation among women in Japan, 2010-2019.
Ishii K; Tabuchi T; Iso H
Cancer Epidemiol; 2023 Jun; 84():102353. PubMed ID: 36989957
[TBL] [Abstract][Full Text] [Related]
12. [Early effects of attendance to the Friuli Venezia Giulia (Northern Italy) mammography screening programme on the incidence of advanced-stage breast cancer: a cohort study].
Giudici F; Bortul M; Clagnan E; Del Zotto S; Franzo A; Giordano L; Gobbato M; Puliti D; Serraino D; Zucchetto A; Zanier L; Zanconati F; Bucchi L
Epidemiol Prev; 2020; 44(2-3):145-153. PubMed ID: 32631014
[TBL] [Abstract][Full Text] [Related]
13. Effects of Attendance to an Organized Fecal Immunochemical Test Screening Program on the Risk of Colorectal Cancer: An Observational Cohort Study.
Baldacchini F; Bucchi L; Giuliani O; Mancini S; Ravaioli A; Vattiato R; Zamagni F; Giorgi Rossi P; Mangone L; Campari C; Sassatelli R; Trande P; Esposito P; Rossi F; Carrozzi G; Triossi O; Fabbri C; Strocchi E; Giovanardi M; Canuti D; Sassoli de Bianchi P; Ferretti S; Falcini F;
Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2373-2382. PubMed ID: 35144023
[TBL] [Abstract][Full Text] [Related]
14. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
[TBL] [Abstract][Full Text] [Related]
15. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
16. Inequalities in participation in colorectal cancer screening programmes: a systematic review.
Mosquera I; Mendizabal N; Martín U; Bacigalupe A; Aldasoro E; Portillo I;
Eur J Public Health; 2020 Jun; 30(3):416-425. PubMed ID: 32361732
[TBL] [Abstract][Full Text] [Related]
17. Proportion and stage distribution of screen-detected and non-screen-detected colorectal cancer in nine European countries: an international, population-based study.
Cardoso R; Guo F; Heisser T; De Schutter H; Van Damme N; Nilbert MC; Tybjerg AJ; Bouvier AM; Bouvier V; Launoy G; Woronoff AS; Cariou M; Robaszkiewicz M; Delafosse P; Poncet F; Walsh PM; Senore C; Rosso S; Lemmens VEPP; Elferink MAG; Tomšič S; Žagar T; Lopez de Munain Marques A; Marcos-Gragera R; Puigdemont M; Galceran J; Carulla M; Sánchez-Gil A; Chirlaque MD; Hoffmeister M; Brenner H
Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):711-723. PubMed ID: 35561739
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer screening; cost-effective in practice?
De Koning HJ
Eur J Radiol; 2000 Jan; 33(1):32-7. PubMed ID: 10674787
[TBL] [Abstract][Full Text] [Related]
19. Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands.
Denters MJ; Deutekom M; Fockens P; Bossuyt PM; Dekker E
BMC Gastroenterol; 2009 Apr; 9():28. PubMed ID: 19393087
[TBL] [Abstract][Full Text] [Related]
20. Temporal trend in socioeconomic inequalities in the uptake of cancer screening programmes in France between 2005 and 2010: results from the Cancer Barometer surveys.
Kelly DM; Estaquio C; Léon C; Arwidson P; Nabi H
BMJ Open; 2017 Dec; 7(12):e016941. PubMed ID: 29247085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
